MYADM antibody (AA 51-150) (Biotin)

Catalog No. ABIN6944174

Product Details anti-MYADM Antibody (Biotin)

Target: MYADM (Myeloid-Associated Differentiation Marker (MYADM))

Binding Specificity: AA 51-150

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This MYADM antibody is conjugated to Biotin

Application: ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB), Immunohistochemistry (Frozen Sections) (IHC (fro))

Specificity: This antibody's immunogen sequence has 91 % homology (10/11 residues) with the Rat MYADM protein and is predicted to work with Rat samples

Cross-Reactivity: Human

Predicted Reactivity: Pig,Horse,Rabbit

Purification: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human MYADM

Isotype: IgG

Application Details

Application Notes: WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at -20°C for 12 months.

Expiry Date: 12 months

Target Details for MYADM

Target: MYADM (Myeloid-Associated Differentiation Marker (MYADM))

Alternative Name: MYADM (MYADM Products)

Synonyms: myadm antibody, MGC79604 antibody, MYADM antibody, MGC140812 antibody, SB135 antibody, D7Wsu62e antibody, myeloid-associated differentiation marker antibody, myeloid associated differentiation marker antibody, myadm antibody, MYADM antibody, Myadm antibody

Background:

Synonyms: MYADM, MYADM_HUMAN, myeloid associated differentiation marker, Myeloid upregulated protein, Myeloid-associated differentiation marker, Protein SB135.

Background: Myeloid-associated differentiation marker (MYADM) is a member of the MAL family with the unique features of having eight transmembrane regions and a ubiquitous pattern of expression and of being found localized at the plasma membrane. MYADM has been found to be associated with the differentiation of hematopoietic cells or acute promyelocytic leukemia cells. MYADM could serve as a new marker for hematopoietic differentiation and is a target for diagnostic, prognostic and/or therapeutic interventions.

Gene ID: 91663

UniProt: Q96S97